Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Viskoper

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Hypertension (Dallas, Tex. : 1979)|September 16, 2000
Efficacy of candesartan cilexetil alone or in combination with amlodipine and hydrochlorothiazide in moderate-to-severe hypertension. UK and Israel Candesartan InvestigatorsG A MacGregor, J R Viskoper, T F Antonios, et al.
Journal of Human Hypertension|May 31, 2002
The different patterns of blood pressure elevation by rofecoxib and nabumetoneT Reitblat, D Zamir, L Estis, et al.
Harefuah|May 1, 1990
[The "Ashkelon" hypertension detection and follow-up program]J R Viskoper, G Ginsburg, S Sherf, et al.
Journal of Human Hypertension|July 22, 2005
Effects of low-dose aspirin on blood pressure and endothelial function of treated hypertensive hypercholesterolaemic subjectsE Magen, J R Viskoper, J Mishal, et al.
Harefuah|August 26, 2000
[Multicenter community-based trial of amlodipine in hypertension in Israel]C Yosefy, J R Viskoper, Y Leshem, et al.
Journal of Human Hypertension|December 1, 1999
Prior antihypertensive treatment and admission blood pressure correlated with clinical outcome and early morning presentation in hypertensive ischaemic stroke patientsC Yosefy, L Linov, J R Viskoper, et al.
Blood Pressure|November 5, 2003
Risk factor profile and achievement of treatment goals among hypertensive patients from the Israeli Blood Pressure Control (IBPC) program--initial cost utility analysisC Yosefy, G M Ginsberg, D Dicker, et al.
Preventive Medicine|November 26, 2003
The Ashkelon Hypertension Detection and Control Program (AHDC Program): a community approach to reducing cardiovascular mortalityC Yosefy, D Dicker, J R Viskoper, et al.
Journal of Human Hypertension|December 1, 1993
Comprehensive individualised nonpharmacological treatment programme for hypertension in physician-nurse clinics: two year follow-upZ Fuchs, J R Viskoper, I Drexler, et al.
Journal of Human Hypertension|September 1, 1996
Repeated fasting and refeeding with 20:5, n-3 eicosapentaenoic acid (EPA): a novel approach for rapid fatty acid exchange and its effect on blood pressure, plasma lipids and hemostasisC Yosefy, J R Viskoper, D Varon, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Hypertension (Dallas, Tex. : 1979)|September 16, 2000
Efficacy of candesartan cilexetil alone or in combination with amlodipine and hydrochlorothiazide in moderate-to-severe hypertension. UK and Israel Candesartan InvestigatorsG A MacGregor, J R Viskoper, T F Antonios, et al.
Journal of Human Hypertension|May 31, 2002
The different patterns of blood pressure elevation by rofecoxib and nabumetoneT Reitblat, D Zamir, L Estis, et al.
Harefuah|May 1, 1990
[The "Ashkelon" hypertension detection and follow-up program]J R Viskoper, G Ginsburg, S Sherf, et al.
Journal of Human Hypertension|July 22, 2005
Effects of low-dose aspirin on blood pressure and endothelial function of treated hypertensive hypercholesterolaemic subjectsE Magen, J R Viskoper, J Mishal, et al.
Harefuah|August 26, 2000
[Multicenter community-based trial of amlodipine in hypertension in Israel]C Yosefy, J R Viskoper, Y Leshem, et al.
Journal of Human Hypertension|December 1, 1999
Prior antihypertensive treatment and admission blood pressure correlated with clinical outcome and early morning presentation in hypertensive ischaemic stroke patientsC Yosefy, L Linov, J R Viskoper, et al.
Blood Pressure|November 5, 2003
Risk factor profile and achievement of treatment goals among hypertensive patients from the Israeli Blood Pressure Control (IBPC) program--initial cost utility analysisC Yosefy, G M Ginsberg, D Dicker, et al.
Preventive Medicine|November 26, 2003
The Ashkelon Hypertension Detection and Control Program (AHDC Program): a community approach to reducing cardiovascular mortalityC Yosefy, D Dicker, J R Viskoper, et al.
Journal of Human Hypertension|December 1, 1993
Comprehensive individualised nonpharmacological treatment programme for hypertension in physician-nurse clinics: two year follow-upZ Fuchs, J R Viskoper, I Drexler, et al.
Journal of Human Hypertension|September 1, 1996
Repeated fasting and refeeding with 20:5, n-3 eicosapentaenoic acid (EPA): a novel approach for rapid fatty acid exchange and its effect on blood pressure, plasma lipids and hemostasisC Yosefy, J R Viskoper, D Varon, et al.
Pageof 3